Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Omnicell (OMCL)
NASDAQ:OMCL
Holding OMCL?
Track your performance easily
OMCL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.12 - $55.75
Previous Close$46.01
Volume324.58K
Average Volume (3M)574.26K
Market Cap
$2.13B
Enterprise Value$2.16B
Total Cash (Recent Filing)$570.60M
Total Debt (Recent Filing)$603.50M
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Feb 06, 2025EPS Estimate
$0.58Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding46,316,825
10 Day Avg. Volume455,031
30 Day Avg. Volume574,258
Standard Deviation0.14
R-Squared0.09
Alpha-0.00943
Financial Highlights & Ratios
Price to Book (P/B)1.73
Price to Sales (P/S)2.00
Price to Cash Flow (P/CF)23.40
P/FCF Ratio38.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.03
Enterprise Value/Gross Profit4.36
Enterprise Value/Ebitda29.87
Forecast
1Y Price Target
$55.43Price Target Upside22.31% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Omnicell News
PremiumCompany Announcements
Omnicell Reports Strong Q3 2024 Financial Results
Bulls Say, Bears Say
Bulls Say
Financial PerformanceOmnicell’s long-term targeted financial algorithm is favorable at a mid-teens revenue growth rate and roughly 400bps of annual margin expansion from 2021 equating to high-teens compounding EBITDA growth.
Product InnovationOmnicell announced a new product release, OmniSphere, a next-generation, cloud native, software workflow engine and data platform.
Robotics Revenue GrowthRobots are estimated to add significant revenue in 2024, contributing approximately 7% of total revenue.
Bears Say
New Product InstallationsTraveler and backup positions may overstate the number of new robot installations, potentially affecting year-over-year comparisons and misleading growth assessments.
Product Revenue GrowthLimited visibility into product revenue growth may make it elusive in future years, creating uncertainty for investors.
XT Upgrade CycleDownside risk exists if the headwind from the completion of the XT upgrade cycle is not offset by new product adoption, impacting future growth potential.
---
Ownership Overview
1.99% Insiders
30.08% Mutual Funds
17.47% Other Institutional Investors
13.90% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OMCL FAQ
What was Omnicell’s price range in the past 12 months?
Omnicell lowest stock price was $25.12 and its highest was $55.74 in the past 12 months.
What is Omnicell’s market cap?
Currently, no data Available
When is Omnicell’s upcoming earnings report date?
Omnicell’s upcoming earnings report date is Feb 06, 2025 which is in 47 days.
How were Omnicell’s earnings last quarter?
Omnicell released its earnings results on Oct 30, 2024. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.419 by $0.141.
Is Omnicell overvalued?
According to Wall Street analysts Omnicell’s price is currently Undervalued.
Does Omnicell pay dividends?
Omnicell does not currently pay dividends.
What is Omnicell’s EPS estimate?
Omnicell’s EPS estimate is $0.58.
How many shares outstanding does Omnicell have?
Omnicell has 46,316,826 shares outstanding.
What happened to Omnicell’s price movement after its last earnings report?
Omnicell reported an EPS of $0.56 in its last earnings report, beating expectations of $0.419. Following the earnings report the stock price went up 32.228%.
Which hedge fund is a major shareholder of Omnicell?
Among the largest hedge funds holding Omnicell’s share is Driehaus Capital Management LLC. It holds Omnicell’s shares valued at 9M.
---
Omnicell Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$55.43 (22.31% Upside)
$55.43 (22.31% Upside)
Blogger Sentiment
Bullish
OMCL Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 43.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $567.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 2.6%
Last 30 Days ▲ 2.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.94%
12-Months-Change
Fundamentals
Return on Equity
-1.46%
Trailing 12-Months
Asset Growth
3.69%
Trailing 12-Months
Company Description
Omnicell
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence; platform and interoperability; central pharmacy dispensing; medication adherence; population health; and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Mountain View, CA.
---
OMCL Company Deck
---
OMCL Earnings Call
Q3 2024
0:00 / 0:00
---
OMCL Stock 12 Month Forecast
Average Price Target
$55.43
▲(22.31% Upside)
Technical Analysis
Best Analysts Covering OMCL
1 Year
1 Year Success Rate
10/17 ratings generated profit
1 Year Average Return
+17.03%
reiterated a buy rating 2 months ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 58.82% of your transactions generating a profit, with an average return of +17.03% per trade.
---